<DOC>
	<DOCNO>NCT01054170</DOCNO>
	<brief_summary>The primary objective study evaluate structural change effect AD9668 airway adults Chronic Obstructive Pulmonary Disease ( COPD ) Multi-Slice Computed Tomography ( MSCT )</brief_summary>
	<brief_title>Effect Structural Changes Airways , Measured MSCT , Twice Daily 60mg AZD9668 12 Weeks Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diagnosis COPD symptom 1 year FEV1/FVC &lt; 70 % FEV1 &gt; = 40 &lt; =70 % predict postbronchodilator Exsmokers least 12 month Past history current evidence clinically significant heart disease Current diagnosis asthma Worsening COPD require hospitalisation and/or treatment antibiotic and/or increase inhale steroid dose and/or oral steroid within 4 week study visit 1b</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Chronic</keyword>
	<keyword>obstructive</keyword>
	<keyword>pulmonary</keyword>
	<keyword>lung</keyword>
	<keyword>respiratory disease</keyword>
	<keyword>efficacy</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>COPD</keyword>
	<keyword>FEV1</keyword>
	<keyword>St Georges Respiratory Questionnaire</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>MSCT</keyword>
</DOC>